Discontinuation of melanoma combination immunotherapy

MeSH terms

• Antineoplastic Agents, Immunological / administration & dosage*
• Antineoplastic Agents, Immunological / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Clinical Trials, Phase II as Topic
• Clinical Trials, Phase III as Topic
• Disease Progression
• Disease-Free Survival
• Humans
• Immunotherapy* / adverse effects
• Immunotherapy* / mortality
• Melanoma / drug therapy*
• Melanoma / immunology
• Melanoma / mortality
• Melanoma / pathology
• Randomized Controlled Trials as Topic
• Skin Neoplasms / drug therapy*
• Skin Neoplasms / immunology
• Skin Neoplasms / mortality
• Skin Neoplasms / pathology
• Treatment Outcome